GlassScriptPhysician profile
Adrian Crichton
NPI 1073997052
$3,018.87
in general payments reported to CMS, 2019-2025
27 companies · $797 in 2025
The $797 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $303 · 2021: $481 · 2022: $687 · 2024: $561 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,357.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $323.38 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $269.63 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Sun Pharmaceutical Industries INC. | $262.16 | 2020-2025 | |
| Allergan, INC. | $243.67 | 2019-2022 | |
| Abbvie INC. | $172.00 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $166.13 | 2019-2022 | |
| Oyster Point Pharma, INC. | $159.21 | 2022-2025 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $149.79 | 2025 | Acthar |
| Johnson & Johnson Vision Care, INC. | $140.04 | 2019-2022 | |
| Biotissue Holdings INC. | $134.40 | 2024 | |
| Rxsight INC | $131.58 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Amgen INC. | $118.72 | 2025 | Tepezza |
| Coopervision INC. | $105.66 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $105.21 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $99.84 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $93.51 | 2024-2025 | Simbrinza, Tryptyr |
| Dompe US, INC. | $76.74 | 2019-2025 | Oxervate |
| Harrow Eye, LLC | $66.73 | 2024-2025 | Vevye |
| Tearlab Corp | $45.97 | 2019 | |
| Aerie Pharmaceuticals, INC. | $29.40 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $24.54 | 2021 | |
| Rayner Intraocular Lenses Limited | $22.99 | 2025 | Rayone Spheric, Rayner Cataract Set 1, Rayone Emv |
| Regeneron Healthcare Solutions, INC. | $21.07 | 2021 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Omeros Corporation | $15.91 | 2020 | |
| Eyevance Pharmaceuticals LLC | $12.29 | 2020 | |
| Visioneering Technologies, INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Crichton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.